What are the current guidelines for administering Iloprost infusions in patients with severe Raynaud's Phenomenon?
Year: 2026
Type: article
Abstract: Iloprost infusions are a recommended treatment for severe Raynaud's Phenomenon, especially after failure of oral therapies. They are administered at doses of 0.5-2.0 ng/kg/min over several days, requiring monitoring for vasodilatory side effects.
Author: Tripdatabase
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7225893561
